FDA approves MSD's once-daily HIV combo Idvynso
MSD (Merck
& Co) has secured a US approval for its two-drug human immunodeficiency
virus (HIV) combination ... |
Low CD4 Count Tied to Cervical Cancer Risk in HIV Infection
A lower CD4 count is associated with a higher risk for cervical carcinoma in situ and cervical cancer in women with HIV infection. View article...